Opinion on the impact of non-monotonic dose responses on EFSA’s human health risk assessments

Colaboración

Año: 2021

More, S; Benford, D; Bennekou, SH; Bampidis, V; Bragard, C; Halldorsson, T; Hernandez-Jerez, A; Koutsoumanis, K; Lambre, C; Machera, K; Mullins, E; Nielsen, SS; Schlatter, J; Schrenk, D; Turck, D; Tarazona, J; Younes, M

Título: EFSA JOURNAL

• Q2